IMBRUVICA

Identification of Imbruvica

No description

Google image searchProduct monograph

Active ingredient

ibrutinib, 140 MG

DIN: 02434407

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 19-NOV-2014

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EL — Bruton's tyrosine kinase (BTK) inhibitors (ATC, ATC/DDD)
• L01EL01 — IBRUTINIB (ATC/DDD)

Reference brand drug: Imbruvica

External Links for Imbruvica

Search on Google

• Imbruvica side effects
• Imbruvica dosage
• ibrutinib side effects
• ibrutinib dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find imbruvica photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.